Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.

Shiffman M, Da B, Goel A, Kwong A, Stein L, Moreno C, Nicoll A, Mehta A, Louvet A, Flamm S, Pyrsopoulos N, Satapathy S, Kuo A, Ganger D, Aloman C, Strasser SI, Tse E, Russo MW, Rockey D, Gray M, Mitchell M, Thursz M, Krebs W, Scott D, Blevins C, Ellis D, Brown J, Sussman N, Lin W.

Open source

DOI: 10.1056/evidoa2400243
Published: 2025-01-28
Container: NEJM Evid
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/evidoa2400243,
  title = {Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.},
  author = {Shiffman M and  Da B and  Goel A and  Kwong A and  Stein L and  Moreno C and  Nicoll A and  Mehta A and  Louvet A and  Flamm S and  Pyrsopoulos N and  Satapathy S and  Kuo A and  Ganger D and  Aloman C and  Strasser SI and  Tse E and  Russo MW and  Rockey D and  Gray M and  Mitchell M and  Thursz M and  Krebs W and  Scott D and  Blevins C and  Ellis D and  Brown J and  Sussman N and  Lin W.},
  year = {2025},
  journal = {NEJM Evid},
  doi = {10.1056/evidoa2400243},
  url = {https://doi.org/10.1056/evidoa2400243}
}

RIS

TY  - JOUR
TI  - Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.
AU  - Shiffman M
AU  -  Da B
AU  -  Goel A
AU  -  Kwong A
AU  -  Stein L
AU  -  Moreno C
AU  -  Nicoll A
AU  -  Mehta A
AU  -  Louvet A
AU  -  Flamm S
AU  -  Pyrsopoulos N
AU  -  Satapathy S
AU  -  Kuo A
AU  -  Ganger D
AU  -  Aloman C
AU  -  Strasser SI
AU  -  Tse E
AU  -  Russo MW
AU  -  Rockey D
AU  -  Gray M
AU  -  Mitchell M
AU  -  Thursz M
AU  -  Krebs W
AU  -  Scott D
AU  -  Blevins C
AU  -  Ellis D
AU  -  Brown J
AU  -  Sussman N
AU  -  Lin W.
PY  - 2025
JO  - NEJM Evid
DO  - 10.1056/evidoa2400243
UR  - https://doi.org/10.1056/evidoa2400243
ER  -

APA

M, S., B, D., A, G., A, K., L, S., C, M., A, N., A, M., A, L., S, F., N, P., S, S., A, K., D, G., C, A., SI, S., E, T., MW, R., D, R., M, G., M, M., M, T., W, K., D, S., C, B., D, E., J, B., N, S., & W., L. (2025). Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.. NEJM Evid. https://doi.org/10.1056/evidoa2400243

Source records

europe-pmc · retrieved 2026-09-25T16:30:45.316Z
hal · retrieved 2026-09-25T16:30:45.350Z